Amplify Therapeutics is dedicated to the development of transformative, disease-modifying therapies for Gaucher disease.
Amplify Therapeutics has raised $533K in total funding. The most recent round was Pre-Seed. The last funding was announced in March 2023.
Amplify Therapeutics's investors include BioInnovation Institute Venture Lab.
Amplify Therapeutics is headquartered in Copenhagen, Denmark.
Amplify Therapeutics is dedicated to the development of transformative, disease-modifying therapies for Gaucher disease.
Amplify Therapeutics is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Amplify Therapeutics — Funding & Investors." VCBacked, March 1, 2023, https://www.vcbacked.co/company/amplify-therapeutics. Accessed August 14, 2026.
VCBacked. (2023). Amplify Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/amplify-therapeutics
{{cite web |title=Amplify Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/amplify-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated